Greeks.Live: Market needs time to digest tariff news, expects prices to bottom out in late March or April
On 4 March, the Greeks.Live Community Journal showed that traders are watching the $86,000-$87,000 level as a key support level as the recent ‘Trump market’ retraces its full course and market sentiment has turned generally bearish. Most traders are concerned about the market's reaction to the Trump tariff announcement, with many seeing yesterday's price action as a trap to liquidate over-leveraged positions.
The market is experiencing high volatility in terms of the impact of Trump's tariffs, with Bitcoin down $8,000-$9,000 from its recent highs, and yesterday's gains have been completely erased. Traders have noticed volatility indicators jumping from below 40 to 70 in a week, creating a difficult trading environment for both long and short sides.
Most believe the market needs time to digest the tariff news and expect prices to bottom out by the end of March or April, while some traders are taking advantage of the sell-off to build up spot and sell options for a premium. The report also notes that volatility is high in near-month term structures and that some traders are implementing calendar spread strategies (selling near options while buying forwards) to take advantage of volatility patterns.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Indonesian Rupiah: Limited relief, challenging backdrop – OCBC
Buying Wind in the Cryptocurrency Market! Significant Activity in Bitcoin, Ethereum, and Solana! Here are the Details…
Hulamin says Paul Baloyi resigns as independent non-executive director
Hulamin said independent non-executive director Paul Baloyi resigned, effective Oct. 2, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hulamin Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S604350), on October 05, 2026, and is solely responsible for the information contained therein.
US Stock Move | Pneumococcal vaccine achieves late-stage clinical trial target, Vaxcyte (PCVX.US) opens more than 50% higher
On Monday, Vaxcyte (PCVX.US) soared more than 50% at the open and was up approximately 53% at the time of writing, with a market capitalization of 12.8 billions USD.
Crypto prices
More
